Morgan Stanley analyst Stephen Byrd downgrades Array Technologies (NASDAQ:ARRY) from Equal-Weight to Underweight and lowers the price target from $17 to $15.
Reported Late Friday, OpGen Announces Pricing Of $7.5M Public Offering Of 2,586,207 Shares Of Common Stock At A Price Of $2.90/Share
OpGen, Inc. (NASDAQ:OPGN, ", OpGen", or ", the Company", )))), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today
